Michael Emerson

Michael Emerson

Ask VT AI
View News Summary
  • Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • Prop 50 aims to reshape California's congressional map, sparking debate over partisan gerrymandering and the future of the state's House representation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Latest News
Ask VT AI
View News Summary
  • Generac's Q3 earnings miss and reduced 2025 sales and margin guidance send shares tumbling, despite long-term growth drivers remaining intact.
  • FDA issues draft guidance to streamline biosimilar approvals, aiming to cut bureaucracy and increase competition for lower-cost biologics.
  • Prop 50 aims to reshape California's congressional map, sparking debate over partisan gerrymandering and the future of the state's House representation.
20 hours
USA flag

United States Politics

Discover the latest news, candidates, 
and key topics of US politics

Most Reported By
News from Michael Emerson